News Release

Translating science-based treatments into clinical settings

'Evidence-based addiction treatment' by Peter Miller, Ph.D.

Book Announcement

Elsevier

Academic Press, a division of Elsevier, would like to announce the publication of a new title in psychology; Evidence-Based Addiction Treatment by Peter Miller, PhD.

The growing emphasis on accountability and cost effectiveness in the field of addictions treatment is leading to major changes in standards of care. Inconsistent practices based solely on clinical intuition rather than hard scientific evidence of treatment efficacy are rapidly becoming unacceptable. Translating science-based treatments into clinical settings is now an important priority. Evidence-Based Addiction Treatment provides a state-of-the-art compilation of assessment and treatment practices with proven effectiveness.

This graduate level textbook for clinical psychology students and psychiatry residents covers evidence-based practices for the assessment and treatment of addiction, and discusses the treatments that work through explicit case examples and contributions by well-known researchers on addiction treatment. Miller gives students the simple ways to evaluate treatment effectiveness, and offers an accompanying web-site with exam questions for students and instructors.

###

ISBN: 9780123743480
PAGES: 488
PUB DATE: June 2009
US PRICE: $69.95
EUR PRICE: €49.95
GBP PRICE: £37.99

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.